Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Cerilliant
Chinese Patent Office
Harvard Business School
Accenture
UBS
McKinsey
Boehringer Ingelheim
McKesson
US Department of Justice

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,470,584

« Back to Dashboard

Summary for Patent: 5,470,584
Title: Diltiazem formulation
Abstract:The present invention is directed to a diltiazem formulation suitable for one a day administration. The formulation contains a blend of diltiazem beads having two differing dissolution profiles.
Inventor(s): Hendrickson; Dennis L. (Overland Park, KS), Dimmitt; Dan C. (Belton, MO), Williams; Mark S. (Kansas City, MO), Skultety; Paul F. (Leawood, KS), Baltezor; Michael J. (Lees Summit, MO)
Assignee: Carderm Capital L.P. (Thalwil, CH)
Application Number:08/394,573
Patent Claim Types:
see list of patent claims
Formulation; Dosage form; Composition; Device;

Drugs Protected by US Patent 5,470,584

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,470,584

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 147982 ➤ Try a Free Trial
Australia 1632692 ➤ Try a Free Trial
Australia 653223 ➤ Try a Free Trial
Canada 2068980 ➤ Try a Free Trial
Germany 69216910 ➤ Try a Free Trial
Denmark 0514814 ➤ Try a Free Trial
European Patent Office 0514814 ➤ Try a Free Trial
Spain 2099764 ➤ Try a Free Trial
Finland 922270 ➤ Try a Free Trial
Greece 3022927 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Teva
Mallinckrodt
McKesson
AstraZeneca
Julphar
Deloitte
Covington
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot